What a compeling editorial (#viewpoint) JAMA Internal Medicine on #AgingResearch & The National Institute on Aging (NIA)-led Science: "We need to move more toward research that abandons reductionism and fully embraces complexity..." Ken Covinsky Sharon Inouye, MD Lona Mody, MD, M.Sc American Geriatrics Society jamanetwork.com/journals/jamai…

NIA - WE absolutely need it! Aging care is SO MUCH MORE than addressing individual organ care ! Ken Covinsky Dr. Mody Sharon Inouye, MD "Crucial for NIH to expand portfolio of research focused not just on maximizing the lifespan but also maintain healthy life expectancy (HLE)"

Viewpoint discusses recent study findings that emphasize mail-order pharmacy dispensing improves access to medication abortion, especially via primary care, where it would not be practical to store medications for dispensing. ja.ma/4dcaS7s

In this randomized clinical trial, cytisinicline for 12 weeks, with behavioral support, demonstrated efficacy for cessation of e-cigarette use at end of treatment and was well tolerated by adults. ja.ma/3yxniHR

New publication from NASEM Health! Speakers at a June 2023 workshop explored the meaning, design, use, and evaluation of #HealthEquity metrics in health care, communities, and other settings. Read here: ow.ly/nwN950SU52r #PopHealthRT #HealthEquityRT #SDOH

Nominate an expert by 8/23 for the NASEM Health #MedPrepForum’s workshop on resilience in health care and #PublicHealth critical infrastructure. Experts in #Cybersecurity, #HealthPolicy and economics, and more are encouraged to submit here: ow.ly/7fuH50SRw2f

.NASEM Health's Food Forum will host a public workshop 9/4-5 to explore science-based risk management, assessment, & communication strategies to improve food safety in domestic & global #FoodSystems. Register: ow.ly/98UP50SKmuE #NASEMFoodForum #FoodSafety #HealthEquity

Nominate an expert by 8/30 for NASEM Health's future workshop on #H5N1 #birdflu research and medical response in the US. Experts in #OneHealth, #FoodSafety, #epidemiology, risk communication, and more are encouraged to participate here: ow.ly/uLBS50SX94m

New NASEM Health publication! Speakers at a March workshop discussed #WomensHealth research and how to fill the gap in scientific understanding of women's physical and mental health conditions. Access the proceedings: ow.ly/GoQG50T1iqv

Join NASEM Health for the second webinar in a three-part series on 9/3 to explore the role of innovative #TherapeuticDevelopment to reduce U.S. #HealthDisparities and disease burden. Register here: ow.ly/xs2t50SUf8h #HealthEconomics

Most viewed from JAMA Internal Medicine: Does treatment w/ semaglutide, 2.4 mg, once weekly affect the risk of developing symptoms of depression or suicidal ideation/behavior vs placebo in people with overweight or obesity without known major psychopathology? ja.ma/3Tw8PTI

GLP-1 drugs associated with reduction of cirrhosis and all-cause mortality in participants with MASLD (metabolic-dysfunction associated steatotic liver disease), but without effect in those with pre-existing cirrhosis. jamanetwork.com/journals/jamai… JAMA Internal Medicine Fasiha Kanwal

When initiated earlier in the disease course, GLP-1 receptor agonists are associated with a reduced risk of progression to cirrhosis in patients with metabolic dysfunction-associated steatotic liver disease. ja.ma/3XHgcdw

Listen to an interview with Fasiha Kanwal, author of "GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease," hosted by Eve Rittenberg and Grace Yuan Zhang. ja.ma/4guHYl8

Across 56 studies and 9225 participants, reactions to direct penicillin challenges were rare, occurring at similar rates to challenges done after allergy testing, showing their potential to expand penicillin allergy delabeling beyond specialist settings. ja.ma/3Ttzf8I

Case report: a woman in her mid 30s with diabetes who had been treated with insulin therapy, no history of diabetic ketoacidosis, and normal levels of C-peptide. ja.ma/4e80bTV

New JAMA Internal Medicine editorial by me and Ken Covinsky arguing that Medicare coverage of lecanemab may be pound foolish, considering the limited potential for benefit, the substantial potential for harm, and better uses for those dollars to support proven preventive and supportive

Thoughtful JAMA Internal Medicine viewpoint by Brad Spellberg on why hospitals should create a "policy to override policies": jamanetwork.com/journals/jamai… Policies are important to standardize processes and procedures and ensure patient safety. But no policy or procedure can anticipate all

Among beneficiaries with COPD, the Medicare Competitive Bidding Program was associated with differentially lower spending but not differential changes in oxygen use or clinical outcomes. ja.ma/3UpFdIl

Always a great learning event!!! MT to all.